Catalent Pharma Solutions, a global provider of drug delivery solutions for drugs, biologics and consumer health products, has appointed Robert Beland to the newly created role of Vice President and General Manager of Softgel Technologies in Europe.
Beland will focus on leading initiatives that accelerate overall growth within the European region, working with other members of the Softgel Leadership Team to refine and execute strategy, strengthen business development and commercial activities, while extending Catalent’s development and manufacturing capabilities. He will be based at Catalent’s office in Cham, Switzerland.
He has more than 25 years’ experience in the services industry, both in the pharma and the vitamins, minerals, and supplements (VMS) space. His professional career includes two years at Catalent’s St Petersburg, Florida, US facility as Vice President and General Manager for Nutritionals. In his extensive career he has led European and North American businesses. Most recently, he was Executive Vice President and Chief Operating Officer at Ricerca Biosciences.
‘Robert’s appointment will help to further strengthen our leadership position in the European softgel market,’ said Aris Gennadios, Catalent’s President of Softgel Technologies. ‘He will particularly focus on driving commercialisation of our recently launched new technologies across the Rx, consumer health and skincare segments, and coordinating our R&D and supply capabilities at our European sites in France, Germany and Italy.’
